Shanghai Operating Income from 2010 to 2024

688193 Stock   42.00  0.94  2.29%   
Shanghai Rendu's Operating Income is increasing over the years with stable fluctuation. Overall, Operating Income is projected to go to about -7.9 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Shanghai Rendu Biotechnology generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2010-12-31
Previous Quarter
-8.3 M
Current Value
-7.9 M
Quarterly Volatility
24.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shanghai Rendu financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Rendu's main balance sheet or income statement drivers, such as Net Interest Income of 8.7 M, Interest Income of 9.2 M or Selling General Administrative of 109.5 M, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Rendu Valuation or Volatility modules.
  
This module can also supplement various Shanghai Rendu Technical models . Check out the analysis of Shanghai Rendu Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rendu financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rendu security.